% alzhub.org topic: akt-gsk-3
% Source: https://alzhub.org/topic/akt-gsk-3
% 3 entries, in the order the page lists them. Built from alzhub.org's own records.
% 0 entries have no readable author in the source record and carry no author field.

@article{curtis2020-32020597,
  author  = {Curtis, D. and Bakaya, K. and Sharma, L. and Bandyopadhyay, S.},
  title   = {{Weighted burden analysis of exome-sequenced late-onset Alzheimer's cases and controls provides further evidence for a role for PSEN1 and suggests involvement of the PI3K/Akt/GSK-3β and WNT signalling pathways}},
  journal = {Annals of human genetics},
  year    = {2020},
  doi     = {10.1111/ahg.12375},
  pmid    = {32020597},
  url     = {https://doi.org/10.1111/ahg.12375}
}

@article{justinthenmozhi2018-29687202,
  author  = {Justin-Thenmozhi, A. and Dhivya Bharathi, M. and Kiruthika, R. and Manivasagam, T. and Borah, A. and Essa, M. M.},
  title   = {{Attenuation of Aluminum Chloride-Induced Neuroinflammation and Caspase Activation Through the AKT/GSK-3β Pathway by Hesperidin in Wistar Rats}},
  journal = {Neurotoxicity research},
  year    = {2018},
  doi     = {10.1007/s12640-018-9904-4},
  pmid    = {29687202},
  url     = {https://doi.org/10.1007/s12640-018-9904-4}
}

@article{wang2018-29223528,
  author  = {Wang, Y. and Chen, S. and Xu, Z. and Yao, W. and Gao, X.},
  title   = {{GLP-1 receptor agonists downregulate aberrant GnT-III expression in Alzheimer's disease models through the Akt/GSK-3β/β-catenin signaling}},
  journal = {Neuropharmacology},
  year    = {2018},
  doi     = {10.1016/j.neuropharm.2017.11.048},
  pmid    = {29223528},
  url     = {https://doi.org/10.1016/j.neuropharm.2017.11.048}
}